Clear Impact logo

2023 Licking County Reportable Disease - Annual Report

Logo

Gastro-Enteric Diseases
Campylobacteriosis
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Campylobacteriosis - YTD
I
2023
56
62
Cyclosporiasis
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Cyclosporiasis - YTD
I
2023
2
4
E.coli, Shiga Toxin-Producing (O157:H7, Not O157, Unknown Serotype)
R
Time Period
Current Actual Value
Current Target Value
2023 CD
E.coli, Shiga Toxin-Producing (O157:H7, Not O157, Unknown Serotype) - YTD
I
2023
9
17
Listeriosis
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Listeriosis - YTD
I
2023
1
4
Salmonellosis
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Salmonellosis - YTD
I
2023
27
35
Shigellosis
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Shigellosis - YTD
I
2023
10
5
Vibriosis - other (not cholera)
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Vibriosis - other (not cholera) - YTD
I
2023
1
3
Yersinosis
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Yersiniosis - YTD
I
2023
8
6
Hepatitis
Hepatitis A
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Hepatitis A - YTD
I
2023
6
55
Hepatitis B
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Perinatal Hepatitis B - YTD
I
2023
0
4
2023 CD
Chronic Hepatitis B (including delta) - YTD
I
2023
23
52
Hepatitis C
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Acute Hepatitis C - YTD
I
2023
4
21
2023 CD
Chronic Hepatitis C - YTD
I
2023
82
163
Other Class B Infectious Diseases
2023 CD
Candida auris
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Candida auris - YTD
I
2023
1
0
CPO
R
Time Period
Current Actual Value
Current Target Value
2023 CD
CPO - YTD
I
2023
12
12
CPO - Colonization Screening
R
Time Period
Current Actual Value
Current Target Value
2023 CD
CPO - Colonization Screen - YTD
I
2023
3
1
2023 CD
Creutzfeldt-Jakob Disease
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Creutzfeldt-Jakob Disease - YTD
I
2023
1
1
Immigrant Investigation
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Immigrant Investigation - YTD
I
2023
4
3
2023 CD
Infant Botulism
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Infant Botulism - YTD
I
2023
1
0
2023 CD
Streptococcal
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Streptococcal - Group A - Invasive - YTD
I
2023
24
18
2023 CD
Streptococcus pneumoniae - invasive antibiotic resistance unknown - YTD
I
2023
26
26
2023 CD
Streptococcus pneumoniae - invasive antibiotic resistant/intermediate - YTD
I
2023
6
7
2023 CD
Varicella
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Varicella - YTD
I
2023
4
8
Respiratory-borne (droplets) and Airborne Diseases
2023 CD
COVID-19
R
Time Period
Current Actual Value
Current Target Value
2023 CD
COVID-19 - YTD
I
2023
4,932
21,100
2023 CD
Haemophilus influenzae (invasive disease)
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Haemophilus influenza (invasive disease) - YTD
I
2023
3
8
2023 CD
Influenza
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Hospitalized Influenza - YTD
I
2023
30
160
2023 CD
Meningitis
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Aseptic/Viral Meningitis - YTD
I
2023
12
19
2023 CD
Bacterial Meningitis (Not N. meningitidis) - YTD
I
2023
2
4
Pertussis
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Pertussis - YTD
I
2023
1
24
2023 CD
Tuberculosis
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Tuberculosis - YTD
I
2023
2
7
Sexually Transmitted Infections (STIs)
2023 CD
Chlamydia
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Chlamydia - YTD
I
2023
382
662
2023 CD
Gonorrhea
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Gonorrhea - YTD
I
2023
75
298
2023 CD
Syphilis (all types/stages)
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Syphilis (all types/stages) - YTD
I
2023
55
41
Vector-borne Diseases
2023 CD
Dengue
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Dengue - YTD
I
2023
1
0
2023 CD
Lyme Disease
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Lyme Disease - YTD
I
2023
223
161
2023 CD
Malaria
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Malaria - YTD
I
2023
2
2
2023 CD
Rocky Mountain Spotted Fever (RMSF)
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Rocky Mountain Spotted Fever (RMSF) - YTD
I
2023
1
3
Waterborne Diseases
2023 CD
Cryptosporidiosis
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Cryptosporidiosis - YTD
I
2023
3
14
2023 CD
Giardiasis
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Giardiasis - YTD
I
2023
3
18
2023 CD
Legionellosis - Legionnaires' Disease
R
Time Period
Current Actual Value
Current Target Value
2023 CD
Legionellosis - YTD
I
2023
13
16

Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.

Scorecard Container Measure Action Actual Value Target Value Tag S A m/d/yy m/d/yyyy